This latest announcement is the least exciting of coming developments imo and the study is also incomplete. The question still remains if stage 1&2 sensitivity in comparison to Roche is significantly better .I can’t see that that is clear in the latest announcement . I think that is what is to be established in the next round of testing ? I still strongly believe this is a buying opportunity.
Ann: Positive results for SubB2M Breast Cancer Test, page-25
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.14M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 2000 | 1 |
View Market Depth
| Last trade - 10.00am 09/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |
Day chart unavailable